Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-13

FDA Approved: ZYNRELEF — Supplemental Application (Heron Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ZYNRELEF (bupivacaine and meloxicam) from Heron Therapeutics, expanding its label/indication for postoperative pain …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYNRELEF (BUPIVACAINE AND MELOXICAM)

Snippet

SUPPL AP for ZYNRELEF (BUPIVACAINE AND MELOXICAM)